Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002260 · ClinicalTrials.gov registry record · NA
An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects
A NA study, sponsored by Lederle Laboratories.
- Completed
- Registry status
- NA
- Development phase
NCT00002260: Completed NA study, sponsored by Lederle Laboratories.
NCT00002260 is a NA study that has completed, run by Lederle Laboratories. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002260, a NA study, has completed, sponsored by Lederle Laboratories.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To characterize the pharmacokinetics of orally administered FLT (in a liquid formulation) after single doses in both the fed and fasting states; to assess the effect of food on the oral bioavailability of FLT
Interventions
- DRUG Alovudine
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002260
The ClinicalTrials.gov registry entry for NCT00002260 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Lederle Laboratories, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alovudine is the first listed.
NCT00002260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002260 about?
NCT00002260 is a clinical study titled "An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects". To characterize the pharmacokinetics of orally administered FLT (in a liquid formulation) after single doses in both the fed and fasting states; to assess the effect of food on the oral bioavailability of FLT
What is the current status of trial NCT00002260?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002260?
The interventions under investigation include: Alovudine (DRUG).
Who is sponsoring clinical trial NCT00002260?
This trial is sponsored by Lederle Laboratories, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.